These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8162977)

  • 1. Plasma concentration of elastase-alpha 1-proteinase inhibitor complex in surfactant-treated preterm neonates with respiratory distress syndrome.
    Tegtmeyer FK; Möller J; Richter A; Wilken B; Fischer T
    Eur Respir J; 1994 Feb; 7(2):260-4. PubMed ID: 8162977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity.
    Brus F; van Oeveren W; Okken A; Oetomo SB
    Pediatrics; 1997 May; 99(5):672-80. PubMed ID: 9113943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema.
    Fujimura M; Kitajima H; Nakayama M
    Pediatrics; 1993 Oct; 92(4):564-9. PubMed ID: 8414828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase-antiproteinase balance in tracheal aspirates from neonates.
    Sluis KB; Darlow BA; Vissers MC; Winterbourn CC
    Eur Respir J; 1994 Feb; 7(2):251-9. PubMed ID: 7909297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome.
    Speer CP; Ruess D; Harms K; Herting E; Gefeller O
    Pediatrics; 1993 Apr; 91(4):794-9. PubMed ID: 8464669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracheobronchial aspirate fluid neutrophil lipocalin, elastase- and neutrophil protease-4-alpha1-antitrypsin complexes, protease inhibitors and free proteolytic activity in respiratory distress syndrome.
    Sveger T; Ohlsson K; Polberger S; Noack G; Mörse H; Laurin S
    Acta Paediatr; 2002; 91(9):934-7. PubMed ID: 12412868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of plasma truncated elastase alpha 1-proteinase inhibitor complexes in patients with inflammatory lung diseases.
    Fujita J; Nakamura H; Yamagishi Y; Yamaji Y; Shiotani T; Irino S
    Chest; 1992 Jul; 102(1):129-34. PubMed ID: 1623739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
    Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
    Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS.
    Tegtmeyer FK; Möller J; Zabel P
    Eur Respir J; 2002 Apr; 19(4):776-9. PubMed ID: 11999008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
    Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
    J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation.
    Merritt TA; Hallman M; Holcomb K; Strayer D; Bloom B; Revak S; Cochrane CG
    J Pediatr; 1986 May; 108(5 Pt 1):741-8. PubMed ID: 3486264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
    Terek D; Gonulal D; Koroglu OA; Yalaz M; Akisu M; Kultursay N
    Pediatr Neonatol; 2015 Aug; 56(4):248-55. PubMed ID: 25603725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
    Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
    Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance.
    Ogden BE; Murphy SA; Saunders GC; Pathak D; Johnson JD
    Am Rev Respir Dis; 1984 Nov; 130(5):817-21. PubMed ID: 6333839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome.
    Brus F; van Oeveren W; Okken A; Bambang SO
    Pediatr Res; 1996 Mar; 39(3):456-63. PubMed ID: 8929866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.